{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T20:48:22Z","timestamp":1785530902605,"version":"3.56.0"},"reference-count":49,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2019,10,31]],"date-time":"2019-10-31T00:00:00Z","timestamp":1572480000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0224299","type":"journal-article","created":{"date-parts":[[2019,10,31]],"date-time":"2019-10-31T18:51:39Z","timestamp":1572547899000},"page":"e0224299","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":25,"title":["A multicenter prospective study of 515 febrile neutropenia episodes in Argentina during a 5-year period"],"prefix":"10.1371","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4426-4126","authenticated-orcid":true,"given":"Roberto L.","family":"Parodi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana","family":"Lagrutta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauro","family":"Tortolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Estefan\u00eda","family":"Navall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda S.","family":"Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gervasio F.","family":"Sasia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucas F.","family":"De Candia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matias A.","family":"Gruvman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oscar","family":"Bottasso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alcides A.","family":"Greca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2019,10,31]]},"reference":[{"key":"pone.0224299.ref001","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/cncr.11882","article-title":"Chemotherapy-induced neutropenia: risks, consequences, and new directions for its management","volume":"100","author":"J Crawford","year":"2004","journal-title":"Cancer"},{"key":"pone.0224299.ref002","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1001\/archinte.1997.00440370063006","article-title":"Human immunodeficiency virus disease-related neutropenia and the risk of hospitalization for bacterial infection","volume":"157","author":"MA Jacobson","year":"1997","journal-title":"Arch Intern Med"},{"key":"pone.0224299.ref003","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1086\/339215","article-title":"2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer","volume":"34","author":"WT Hughes","year":"2002","journal-title":"Clin Infect Dis"},{"key":"pone.0224299.ref004","first-page":"209","article-title":"Myeloid toxicity of cancer treatment","volume":"3","author":"S Kurtin","year":"2012","journal-title":"J Adv Pract Oncol"},{"issue":"suppl.1","key":"pone.0224299.ref005","first-page":"7","article-title":"Gu\u00edas de recomendaciones sobre diagn\u00f3stico, tratamiento y prevenci\u00f3n de infecciones en pacientes con c\u00e1ncer 2013","volume":"46","author":"Sociedad Argentina De Infectologia","year":"2014","journal-title":"Rev. argent. microbiol"},{"issue":"Suppl 4","key":"pone.0224299.ref006","doi-asserted-by":"crossref","first-page":"S240","DOI":"10.1086\/427329","article-title":"Infections in patients with febrile neutropenia: epidemiology, microbiology, and risk stratification","volume":"40","author":"C Viscoli","year":"2005","journal-title":"Clin Infect Dis"},{"key":"pone.0224299.ref007","doi-asserted-by":"crossref","first-page":"e1004651","DOI":"10.1371\/journal.ppat.1004651","article-title":"Neutrophils: Between host defence, immune modulation, and tissue injury","volume":"11","author":"P Kruger","year":"2015","journal-title":"PLoS Pathog"},{"key":"pone.0224299.ref008","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1093\/cid\/cir073","article-title":"Infectious Diseases Society of America. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of America","volume":"52","author":"AG Freifeld","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"Suppl 4","key":"pone.0224299.ref009","first-page":"S82","article-title":"Management of infection in cancer patients. Studies of the EORTC International Antimicrobial Therapy Group (IATG)","volume":"38","author":"EORTC International Antimicrobial Therapy Group","year":"2002","journal-title":"Eur J Cancer"},{"issue":"Suppl 5","key":"pone.0224299.ref010","doi-asserted-by":"crossref","first-page":"v252","DOI":"10.1093\/annonc\/mdq196","article-title":"ESMO Guidelines Working Group. Management of febrile neutropenia: ESMO Clinical Practice Guidelines","volume":"21","author":"J de Naurois","year":"2010","journal-title":"Ann Oncol"},{"key":"pone.0224299.ref011","doi-asserted-by":"crossref","first-page":"3038","DOI":"10.1200\/JCO.2000.18.16.3038","article-title":"The Multinational Association for Supportive Care in Cancer risk index: A multinational scoring system for identifying low-risk febrile neutropenic cancer patients","volume":"18","author":"J Klastersky","year":"2000","journal-title":"J Clin Oncol"},{"key":"pone.0224299.ref012","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1097\/00000421-198212000-00014","article-title":"Toxicity and response criteria of the Eastern Cooperative Oncology Group","volume":"5","author":"MM Oken","year":"1982","journal-title":"Am J Clin Oncol"},{"key":"pone.0224299.ref013","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/bjc.1993.140","article-title":"Performance status assessment in cancer patients. An inter-observer variability study","volume":"67","author":"JB S\u00f8rensen","year":"1993","journal-title":"Br J Cancer"},{"key":"pone.0224299.ref014","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s00520-007-0334-8","article-title":"Management of febrile neutropenia in solid tumours and lymphomas using the Multinational Association for Supportive Care in Cancer (MASCC) risk index: feasibility and safety in routine clinical practice","volume":"16","author":"H Innes","year":"2008","journal-title":"Support Care Cancer"},{"key":"pone.0224299.ref015","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1007\/s00520-013-1758-y","article-title":"The Multinational Association for Supportive Care in Cancer (MASCC) risk index score: 10 years of use for identifying low-risk febrile neutropenic cancer patients","volume":"21","author":"J Klastersky","year":"2013","journal-title":"Support Care Cancer"},{"key":"pone.0224299.ref016","first-page":"555","article-title":"Febrile neutropenia: a prospective study to validate the Multinational Association of Supportive Care of Cancer (MASCC) risk-index score","volume":"12","author":"A Uys","year":"2004","journal-title":"Support Care Cancer"},{"key":"pone.0224299.ref017","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1038\/bjc.2011.284","article-title":"Prognostic evaluation of febrile neutropenia in apparently stable adult cancer patients","volume":"105","author":"A Carmona-Bayonas","year":"2011","journal-title":"Br J Cancer"},{"key":"pone.0224299.ref018","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.critrevonc.2011.03.003","article-title":"Reporting of myelotoxicity associated with emerging regimens for the treatment of selected solid tumors","volume":"81","author":"A Chan","year":"2012","journal-title":"Crit Rev Oncol Hematol"},{"key":"pone.0224299.ref019","first-page":"385","article-title":"Factores de mal pron\u00f3stico en pacientes internados con neutropenia al inicio del episodio febril","volume":"66","author":"C G\u00f3mez Roca","year":"2006","journal-title":"M. Medicina (B Aires)"},{"key":"pone.0224299.ref020","doi-asserted-by":"crossref","first-page":"453","DOI":"10.47102\/annals-acadmedsg.V39N6p453","article-title":"Prospective audit of febrile neutropenia management at a tertiary university hospital in Singapore","volume":"39","author":"J Jin","year":"2010","journal-title":"Ann Acad Med Singapore"},{"key":"pone.0224299.ref021","doi-asserted-by":"crossref","first-page":"106","DOI":"10.4067\/S0716-10182009000200001","article-title":"Etiolog\u00eda de episodios de neutropenia febril en pacientes adultos con c\u00e1ncer hematol\u00f3gico y de \u00f3rganos s\u00f3lidos en el Hospital Cl\u00ednico Universidad Cat\u00f3lica, Santiago-Chile","volume":"26","author":"B R Rabagliati","year":"2009","journal-title":"Rev Chilena Infectol"},{"key":"pone.0224299.ref022","doi-asserted-by":"crossref","first-page":"721","DOI":"10.4067\/S0716-10182014000600013","article-title":"Epidemiolog\u00eda de neutropenia febril en pacientes adultos con leucemia aguda y linfoma. Estudio de cohorte en hospitales p\u00fablico y privado de Santiago, Chile","volume":"31","author":"R Rabagliati","year":"2014","journal-title":"Cruz R. Rev Chilena Infectol"},{"key":"pone.0224299.ref023","doi-asserted-by":"crossref","first-page":"359","DOI":"10.3855\/jidc.197","article-title":"Evaluation of febrile neutropenic attacks in a tertiary care medical center in Turkey","volume":"2","author":"S Sacar","year":"2008","journal-title":"J Infect Dev Ctries"},{"issue":"Suppl 1","key":"pone.0224299.ref024","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.1016\/j.ijantimicag.2007.06.012","article-title":"Bacteraemia in febrile neutropenic cancer patients","volume":"30","author":"J Klastersky","year":"2007","journal-title":"Int J Antimicrob Agents"},{"key":"pone.0224299.ref025","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1200\/JCO.1992.10.2.316","article-title":"Risk assessment in cancer patients with fever and neutropenia: a prospective, two-center validation of a prediction rule","volume":"10","author":"JA Talcott","year":"1992","journal-title":"J Clin Oncol"},{"key":"pone.0224299.ref026","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1002\/cncr.25691","article-title":"Predicting individual risk of neutropenic complications in patients receiving cancer chemotherapy","volume":"117","author":"GH Lyman","year":"2011","journal-title":"Cancer"},{"key":"pone.0224299.ref027","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1002\/cncr.21144","article-title":"Bacterial infections in low-risk, febrile neutropenic patients","volume":"104","author":"M Kamana","year":"2005","journal-title":"Cancer"},{"key":"pone.0224299.ref028","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1001\/archinte.1988.00380120031007","article-title":"The medical course of cancer patients with fever and neutropenia. Clinical identification of a low-risk subgroup at presentation","volume":"148","author":"JA Talcott","year":"1988","journal-title":"Arch Intern Med"},{"key":"pone.0224299.ref029","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/0002-9343(82)90594-0","article-title":"Empiric antibiotic and antifungal therapy for cancer patients with prolonged fever and granulocytopenia","volume":"72","author":"PA Pizzo","year":"1982","journal-title":"Am J Med"},{"key":"pone.0224299.ref030","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.ijid.2006.12.008","article-title":"Bloodstream infections in febrile neutropenic patients at a tertiary care center in Lebanon: a view of the past decade","volume":"11","author":"ZA Kanafani","year":"2007","journal-title":"Int J Infect Dis"},{"key":"pone.0224299.ref031","first-page":"CD004386","article-title":"Antibiotic prophylaxis for bacterial infections in afebrile neutropenic patients following chemotherapy","volume":"1","author":"A Gafter-Gvili","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"pone.0224299.ref032","doi-asserted-by":"crossref","first-page":"979","DOI":"10.7326\/0003-4819-142-12_Part_1-200506210-00008","article-title":"Meta-analysis: antibiotic prophylaxis reduces mortality in neutropenic patients","volume":"42","author":"A Gafter-Gvili","year":"2005","journal-title":"Ann Intern Med"},{"key":"pone.0224299.ref033","first-page":"CD004386","article-title":"Antibiotic prophylaxis for bacterial infections in afebrile neutropenic patients following chemotherapy (Review)","volume":"4","author":"A Gafter-Gvili","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"key":"pone.0224299.ref034","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1093\/jac\/dkl425","article-title":"Effect of quinolone prophylaxis in afebrile neutropenic patients on microbial resistance: systematic review and meta-analysis","volume":"59","author":"A Gafter-Gvili","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"pone.0224299.ref035","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1086\/514550","article-title":"Outcomes of bacteremia in patients with cancer and neutropenia: observations from two decades of epidemiological and clinical trials","volume":"25","author":"LS Elting","year":"1997","journal-title":"Clin Infect Dis"},{"issue":"suppl 5","key":"pone.0224299.ref036","doi-asserted-by":"crossref","first-page":"v111","DOI":"10.1093\/annonc\/mdw325","article-title":"ESMO Guidelines Committee. Management of febrile neutropaenia: ESMO Clinical Practice Guidelines","volume":"27","author":"J Klastersky","year":"2016","journal-title":"Ann Oncol"},{"issue":"Suppl 1","key":"pone.0224299.ref037","doi-asserted-by":"crossref","first-page":"S30","DOI":"10.1016\/j.ijantimicag.2008.06.017","article-title":"Bloodstream infections in cancer patients with febrile neutropenia","volume":"32","author":"R Feld","year":"2008","journal-title":"Int J Antimicrob Agents"},{"key":"pone.0224299.ref038","first-page":"986938","article-title":"Treatment of febrile neutropenia and prophylaxis in hematologic malignancies: a critical review and update","author":"P Villafuerte-Gutierrez","year":"2014","journal-title":"Adv Hematol"},{"key":"pone.0224299.ref039","doi-asserted-by":"crossref","first-page":"3187","DOI":"10.1200\/JCO.2006.06.4451","article-title":"2006 update of recommendations for the use of white blood cell growth factors: an evidence-based clinical practice guideline","volume":"24","author":"TJ Smith","year":"2006","journal-title":"J Clin Oncol"},{"key":"pone.0224299.ref040","doi-asserted-by":"crossref","first-page":"3199","DOI":"10.1200\/JCO.2015.62.3488","article-title":"American Society of Clinical Oncology. Recommendations for the Use of WBC Growth Factors: American Society of Clinical Oncology Clinical Practice Guideline Update","volume":"33","author":"T. J. Smith","year":"2015","journal-title":"J Clin Oncol"},{"key":"pone.0224299.ref041","doi-asserted-by":"crossref","first-page":"3558","DOI":"10.1200\/JCO.2000.18.20.3558","article-title":"American Society of Clinical Oncology. 2000 update of recommendations for the use of hematopoietic colony-stimulating factors: evidence-based, clinical practice guidelines","volume":"18","author":"H Ozer","year":"2000","journal-title":"American Society of Clinical Oncology Growth Factors Expert Panel. J Clin Oncol"},{"key":"pone.0224299.ref042","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.cmi.2017.03.024","article-title":"Comparison of antipseudomonal \u03b2-lactams for febrile neutropenia empiric therapy: systematic review and network meta-analysis","volume":"23","author":"N Horita","year":"2017","journal-title":"Clin Microbiol Infect"},{"key":"pone.0224299.ref043","article-title":"Gu\u00edas de recomendaciones sobre diagn\u00f3stico, tratamiento y prevenci\u00f3n de infecciones en pacientes con c\u00e1ncer","author":"JA Cozzi","year":"2008","journal-title":"Consenso de la Sociedad Argentina de Infectolog\u00eda, Comisi\u00f3n de Infecciones en el Paciente Neopl\u00e1sico y Trasplantado de M\u00e9dula \u00d3sea"},{"key":"pone.0224299.ref044","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.ijid.2007.02.002","article-title":"Bacteremia in patients with febrile neutropenia after chemotherapy at a university medical center in Malaysia","volume":"6","author":"ND Baskaran","year":"2007","journal-title":"Int J Infect Dis"},{"key":"pone.0224299.ref045","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.3889\/oamjms.2018.310","article-title":"Effect of Combination Therapy of Ceftazidime\/Amikacin and Monotherapy with Imipenem on the Treatment of Fever and Neutropenia in Patients with Cancers","volume":"6","author":"AA Anoshirvani","year":"2018","journal-title":"Open Access Maced J Med Sci"},{"key":"pone.0224299.ref046","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1007\/s00277-017-3098-3","article-title":"Diagnosis and empirical treatment of fever of unknown origin (FUO) in adult neutropenic patients: guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO)","volume":"96","author":"WJ Heinz","year":"2017","journal-title":"Ann Hematol"},{"key":"pone.0224299.ref047","article-title":"Management of febrile neutropenia in special consideration of the role of antimicrobial de-escalation","author":"M Schmidt-Hieber","year":"2019","journal-title":"Expert Rev Anti Infect Ther"},{"key":"pone.0224299.ref048","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1046\/j.1365-2141.2000.02014.x","article-title":"Towards a targeted, risk-based, antifungal strategy in neutropenic patients","volume":"110","author":"HG Prentice","year":"2000","journal-title":"Br J Haematol"},{"key":"pone.0224299.ref049","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1056\/NEJM200201243460402","article-title":"Persistent fever in patients with neutropenia","volume":"346","author":"L Corey","year":"2002","journal-title":"N Engl J Med"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0224299","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,22]],"date-time":"2023-09-22T10:11:51Z","timestamp":1695377511000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0224299"}},"subtitle":[],"editor":[{"given":"Guillermo H.","family":"Giambartolomei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2019,10,31]]},"references-count":49,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2019,10,31]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0224299","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,31]]}}}